ICLR Stock News & Catalysts – ICON Public

FEATURED

ICON Launches FIRECREST AI-Directed Video Engine, Changing the Economics of Site Communications

ICON plc (NASDAQ:ICLR), a world-leading clinical research organisation, today announced the release of AI-directed video production capabilities within its FIRECREST site & patient communications platform. ICON’s

Summary

Nov 5, 2026, 8:00 AM ·Business Wire

RECENT

ICON Reports Third Quarter 2026 Results

Third Quarter 2026 Key Highlights Strong commercial performance with net business wins in the quarter of $3,150 million; a net book-to-bill of 1.56x and closing backlog of $24.5 billion, up 4.8%

Oct 27, 2026, 4:43 PM ·Business Wire

ICON Schedules Third Quarter 2026 Earnings Conference Call

ICON plc, (NASDAQ:ICLR) a world-leading clinical research organization, today announced that it will release its financial results for the third quarter 2026 after the market closes on Tuesday, October 27, 2026. The

Oct 8, 2026, 8:00 AM ·Business Wire

ICON Releases 2025 ICON Cares Report, Highlighting Progress in Patient Impact, Innovation and Sustainability

ICON plc (NASDAQ:ICLR) ("ICON"), a world-leading clinical research organisation, today releases its ICON Cares 2025 Report which outlines how the company is delivering on its environmental, social and

Aug 20, 2026, 8:30 AM ·Business Wire

ICON Announces Pricing of USD 2.15 Billion Notes

ICON plc (NASDAQ:ICLR) ("ICON"), a world-leading clinical research organization, today announced the pricing by its wholly-owned subsidiary, ICON Investments Six Designated Activity Company (the

Aug 6, 2026, 6:30 AM ·Business Wire

ICON Announces Private Offering of Notes

ICON plc (NASDAQ:ICLR) ("ICON"), a world-leading clinical research organization, announced today that its wholly-owned subsidiary, ICON Investments Six Designated Activity Company (the "Issuer"),

Aug 4, 2026, 8:39 AM ·Business Wire

ICON Announces Results of Annual General Meeting

ICON plc (NASDAQ:ICLR), a world-leading clinical research organization, today announced that all resolutions at the Annual General Meeting of the company (AGM) held on July 31, 2026 were duly passed by shareholders.

Jul 31, 2026, 4:15 PM ·Business Wire

ICON Reports Second Quarter 2026 Results

Highlights Quarter two revenue of $2,063.5 million, an increase of 1.4% on quarter one 2026. Quarter two adjusted EBITDA of $327.2 million or 15.9% of revenue, an increase of 3.0% on quarter one 2026. GAAP net

Jul 29, 2026, 4:15 PM ·Business Wire

ICON announces multi-year collaboration with Anthropic to bring frontier AI to clinical trials

ICON plc (NASDAQ:ICLR) today announced a multi-year collaboration with Anthropic to bring Claude’s AI capabilities across the clinical trial lifecycle. The collaboration further advances ICON’s digital innovation and

Jul 28, 2026, 7:00 AM ·Business Wire

ICON Schedules Second Quarter 2026 Earnings Conference Call

ICON plc, (NASDAQ:ICLR) a world-leading clinical research organization, today announced that it will release its financial results for the second quarter 2026 after the market closes on Wednesday, July 29, 2026. The

Jul 22, 2026, 6:00 AM ·Business Wire

INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in ICON plc (ICLR) to Contact Law Firm

NEW YORK, July 09, 2026 (GLOBE NEWSWIRE) -- Moore Law, PLLC, a shareholder litigation law firm located on Wall Street, is investigating: ICON plc (NASDAQ:ICLR) shareholders should email fletcher@fmoorelaw.com What

Jul 9, 2026, 4:51 PM ·Globe Newswire

ICON Reports First Quarter 2026 Results

Highlights Quarter one revenue of $2,034.0 million, an increase of 0.9% on quarter one 2025. Quarter one adjusted EBITDA of $317.7 million or 15.6% of revenue. GAAP net income for the quarter of $104.8 million

Jun 23, 2026, 4:15 PM ·Business Wire

ICON selects Microsoft as a preferred technology partner to power AI-enabled clinical development

ICON plc (NASDAQ:ICLR) today announced that it has selected Microsoft as a preferred technology partner – further advancing ICON’s previously announced plan to invest in digital innovation and AI over the next three

Jun 22, 2026, 7:00 AM ·Business Wire

ICON Schedules First Quarter 2026 Earnings Conference Call

ICON plc, (NASDAQ:ICLR) a world-leading clinical research organization, today announced that it will release its financial results for the first quarter 2026 after the market closes on Tuesday, June 23, 2026. The

Jun 17, 2026, 4:15 PM ·Business Wire

ICON Reports Fourth Quarter and Full Year 2025 Results and Provides Outcome of Audit Committee Investigation

Highlights Quarter four revenue was $2,112.5 million. Full year revenue was $8,251 million. Quarter four adjusted EBITDA of $327.1 million or 15.5% of revenue; full year adjusted EBITDA of $1,530.7 million or

May 27, 2026, 4:33 PM ·Business Wire

ICON Public Limited Company ICLR · News